Enzyme Replacement Therapy

Name
Enzyme Replacement Therapy
Accession Number
DBCAT000147
Description
Not Available
Drugs
DrugDrug Description
ImigluceraseA form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.
AlgluceraseA form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.
Taliglucerase alfaA hydrolytic lysosomal glucocerebroside specific enzyme, used for long term enzyme replacement therapy in patients with Type 1 Gaucher disease.
Asfotase alfaAn enzyme replacement therapy used for the treatment of perinatal/infantile and juvenile onset hypophosphatasia (HPP).
ElapegademaseA recombinant adenosine deaminase used to treat adenosine deaminase severe combined immune deficiency.
Drugs & Drug Targets
DrugTargetType
ImigluceraseGlucocerebrosidetarget
AlgluceraseGlucocerebrosidetarget
Taliglucerase alfaGlucocerebrosidetarget
Asfotase alfaSphingosine 1-phosphate receptor 1target
Asfotase alfaPyrophosphatetarget
ElapegademaseAdenosinetarget